RSS Feeds
Search

Articles

Pharmalicensing brings you advice, commentary and analysis from industry experts.

Articles

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
US Oncology, Inc. - SWOT Analysis
Nov 2010 - 26 pages - $125
FDA Approval for Xgeva (denosumab): Novel Therapies to Drive the Bone Metastases Therapy Market
Dec 2010 - 5 pages - $500
The OTC Pharmaceutical Market in Emerging Countries
Aug 2010 - 121 pages - $3,835
Supportive Care in Oncology Market Forecast
Nov 2009 - $15,200
Bone Cancer Global Clinical Trials Review, Q4, 2010
Oct 2010 - 43 pages - $1,000
Stakeholder Opinions: Bone Metastases - Impending patent expiries may help make or break newer agents
Mar 2008 - 100 pages - $3,800
The Return of the Rx to OTC Switch: Market Analysis and Product Management Strategies
Apr 2008 - 52 pages - $1,995
US Oncology, Inc.: SWOT Analysis & Company Profile
Dec 2010 - 19 pages - $99
Bone Cancer Global Clinical Trials Review, H2, 2011
Aug 2011 - 109 pages - $1,000
Emerging Technologies: New Antibody-Based Technologies
Sep 2011 - 62 pages - $5,700
More Related Market Research Reports >>>

Your selection

Industry sector
Pharmaceutical del
OTC/Non-Prescription del
Therapeutic target
Oncology del
Bone cancer del
Year
2010 del

Browse By

Therapeutic target
Chondrosarcoma
Ewings Sarcoma
Osteosarcoma
Spindle sarcoma

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us